Capital investment in production facilities and research and development functions
First written in FY2016. 20 of 34 entries say "Advanced", first in FY2019-Q2. Latest entry: FY2027-H1.
8 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「This was mainly due to ¥6,551 million in payments for the acquisition of property, plant and equipment and ¥3,912 million in payments for the acquisition of investment securities during the interim consolidated fiscal period.」
Payments for the acquisition of property, plant and equipment amounted to ¥6,551 million, up from ¥5,234 million in the same period of the previous year. Investment in production facilities, research and development functions and other areas continued. - 2026-10-08Advancediyakutsushinsha.com
「2031年度の業績目標は、売上高4640 億円、営業利益598億円、営業利益率12.9％、海外売上比率 56％、配当性向 40％。」
中長期の財務予測に配当性向40％が盛り込まれ、株主還元に関する定量目標が示された。 - FY2026AdvancedAnnual report
「Capital investment during the consolidated fiscal year under review amounted to ¥15,030 million.」
Capital investment increased from ¥9,211 million in the previous fiscal year to ¥15,030 million. In Japan, investment focused mainly on expanding production facilities at Rohto Nitten, while in Asia it focused mainly on expanding production facilities at Rohto Indonesia. - FY2026-H1AdvancedAnnual report
「This was mainly due to ¥5,234 million in payments for the acquisition of property, plant and equipment and ¥1,670 million in payments for the acquisition of investment securities during the interim consolidated fiscal period.」
Payments for the acquisition of property, plant and equipment increased from ¥5,025 million in the same period of the previous year to ¥5,234 million, while investment in production facilities and other areas continued. - FY2025-H1AdvancedAnnual report
「This was mainly due to expenditures of ¥5,025 million for the acquisition of property, plant and equipment.」
Payments for the acquisition of property, plant and equipment during the interim consolidated fiscal period amounted to ¥5,025 million, and investment in production facilities and other areas continued. - FY2024Continued Capital Investment; Lower Investment AmountAnnual report
「Capital investment during the consolidated fiscal year under review amounted to ¥9,211 million.」
Capital investment in production facilities and research and development functions continued, with ¥6,345 million invested in Japan and ¥1,771 million in Asia. The total declined from ¥10,564 million in the previous fiscal year to ¥9,211 million. - FY2023AdvancedAnnual report
「In September 2022, a new factory building began operations at the Ueno Technical Center in Iga, Mie Prefecture, our main manufacturing facility.」
Capital investment amounted to ¥10,564 million, and a new factory building at the Ueno Techno Center began operations in September 2022. The Company describes the expansion of production and research and development facilities based on specific operating results. - FY2023-Q2Decline in spending on property, plant and equipmentAnnual report
「This was mainly due to expenditures of ¥4,134 million for the acquisition of property, plant and equipment and ¥1,608 million for the acquisition of investment securities.」
Payments for the acquisition of property, plant and equipment amounted to ¥4,134 million, down from ¥4,668 million in the same period of the previous year. Capital investment continued. - FY2022-Q2AdvancedAnnual report
「This was mainly due to expenditures of ¥4,668 million for the acquisition of property, plant and equipment and ¥2,723 million for the acquisition of investment securities, while proceeds of ¥10,335 million were received from the acquisition of shares in a subsidiary resulting in a change in the scope of consolidation.」
During the first six months of the consolidated fiscal year, ¥4,668 million was spent on the acquisition of property, plant and equipment, and investment in production facilities and other areas continued. - FY2021AdvancedAnnual report
「Capital investment during the consolidated fiscal year amounted to ¥8,815 million.」
Capital investment amounted to ¥8,815 million, including ¥7,139 million invested in production facilities in Japan and ¥1,475 million in production facilities in Vietnam in Asia. At the Ueno Plant, the Company outlined a plan involving total investment of ¥9,000 million, completion scheduled for November 2021, and a 50% increase in production capacity. - FY2021-Q2AdvancedAnnual report
「This was mainly due to expenditures of ¥3,482 million for the acquisition of property, plant and equipment and ¥543 million for the acquisition of investment securities, while proceeds of ¥349 million were received from the redemption of time deposits.」
Payments for the acquisition of property, plant and equipment during the first six months amounted to ¥3,482 million, up from ¥2,251 million in the same period of the previous year. - FY2020AdvancedAnnual report
「Capital investment during the consolidated fiscal year amounted to ¥6,250 million.」
The Company continued to expand production facilities and strengthen research and development functions, investing ¥6,250 million in capital expenditures during the period, including ¥5,009 million in Japan and ¥814 million in Asia. - FY2020-Q2Lower Capital ExpenditureAnnual report
「Cash used in investing activities during the first six months of the consolidated fiscal year decreased by ¥4,389 million from the same period of the previous year to ¥2,457 million. This was due mainly to ¥2,251 million in payments for the acquisition of property, plant and equipment and ¥1,896 million in payments for the acquisition of investment securities, partly offset by ¥2,129 million in proceeds from the sale of property, plant and equipment.」
Payments for the acquisition of property, plant and equipment amounted to ¥2,251 million, down from ¥4,597 million in the same period of the previous year. Although investment continued, capital investment spending decreased during the period. - FY2019-Q2AdvancedAnnual report
「Cash used in investing activities during the first six months of the consolidated fiscal year increased by ¥1,674 million from the same period of the previous year to ¥6,847 million. This was mainly due to ¥4,597 million in payments for the acquisition of property, plant and equipment and ¥1,668 million in payments for the acquisition of investment securities.」
Payments for the acquisition of property, plant and equipment during the first six months amounted to ¥4,597 million, up from ¥2,604 million in the same period of the previous year. Investments in production facilities and other areas are disclosed in specific monetary amounts. - FY2018-Q2RestatedAnnual report
「This was mainly due to expenditures of ¥2,604 million for the acquisition of property, plant and equipment and ¥2,071 million for the acquisition of investment securities.」
During the first six months of the consolidated fiscal year, ¥2,604 million was spent on the acquisition of property, plant and equipment, and capital investment in production, research and development functions and other areas continued. - FY2017Lower capital investmentAnnual report
「Capital investment during the consolidated fiscal year amounted to ¥3,853 million.」
Capital investment in expanding production facilities and strengthening research and development functions continued, but the amount invested declined from ¥4,361 million in the previous fiscal year to ¥3,853 million. ¥3,134 million was invested in Japan and ¥470 million in Asia. - FY2017-Q2RestatedAnnual report
「Cash used in investing activities during the first six months of the consolidated fiscal year amounted to ¥4,679 million, an increase of ¥3,143 million from the same period of the previous year. This was mainly due to ¥2,670 million in payments for the acquisition of investment securities, ¥1,617 million in payments for the acquisition of property, plant and equipment, and ¥674 million in payments for long-term loans, partly offset by ¥512 million in proceeds from the redemption of time deposits.」
The Company spent ¥1,617 million on the acquisition of property, plant and equipment, but the filing does not specify detailed uses such as production facilities or research and development functions. - FY2016First statedAnnual report
「The Group has continued to make capital investments focused mainly on expanding production facilities and strengthening its research and development capabilities. During the consolidated fiscal year, investments were made primarily at the Company, クオリテックファーマ㈱ and The Mentholatum Company, China.」
Capital investment during the consolidated fiscal year amounted to ¥4,361 million. In Japan, ¥3,221 million was invested in expanding production facilities, while in Asia, ¥604 million was invested in expanding production facilities at The Mentholatum Company, China.